- Home
- STRO vs SEAT Comparison
STRO vs SEAT Comparison
Compare STRO & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- SEAT
- Stock Information
- Founded
- STRO 2003
- SEAT 2001
- Country
- STRO United States
- SEAT United States
- Employees
- STRO N/A
- SEAT N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- SEAT Industrial Machinery/Components
- Sector
- STRO Health Care
- SEAT Industrials
- Exchange
- STRO Nasdaq
- SEAT Nasdaq
- Market Cap
- STRO 94.9M
- SEAT 96.5M
- IPO Year
- STRO 2018
- SEAT N/A
- Fundamental
- Price
- STRO $0.89
- SEAT $7.19
- Analyst Decision
- STRO Hold
- SEAT Buy
- Analyst Count
- STRO 7
- SEAT 8
- Target Price
- STRO $1.97
- SEAT $33.13
- AVG Volume (30 Days)
- STRO 782.2K
- SEAT 157.6K
- Earning Date
- STRO 11-06-2025
- SEAT 11-06-2025
- Dividend Yield
- STRO N/A
- SEAT N/A
- EPS Growth
- STRO N/A
- SEAT N/A
- EPS
- STRO N/A
- SEAT N/A
- Revenue
- STRO $105,646,000.00
- SEAT $643,775,000.00
- Revenue This Year
- STRO $65.48
- SEAT N/A
- Revenue Next Year
- STRO N/A
- SEAT N/A
- P/E Ratio
- STRO N/A
- SEAT N/A
- Revenue Growth
- STRO N/A
- SEAT N/A
- 52 Week Low
- STRO $0.52
- SEAT $7.04
- 52 Week High
- STRO $3.01
- SEAT $100.00
- Technical
- Relative Strength Index (RSI)
- STRO 48.24
- SEAT 26.17
- Support Level
- STRO $0.81
- SEAT $7.62
- Resistance Level
- STRO $0.95
- SEAT $8.21
- Average True Range (ATR)
- STRO 0.08
- SEAT 0.88
- MACD
- STRO -0.00
- SEAT -0.10
- Stochastic Oscillator
- STRO 53.02
- SEAT 4.26
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.